ATYR
aTyr Pharma, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$80.79M
P/E Ratio
—
EPS
$-0.80
Beta
0.65
52W High
$7.29
52W Low
$0.64
50-Day MA
$0.88
200-Day MA
$2.19
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About aTyr Pharma, Inc.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 190,000 |
| Gross Profit (TTM) | $-60.03M |
| EBITDA | $-76.96M |
| Operating Margin | -40856.00% |
| Return on Equity | -108.10% |
| Return on Assets | -51.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.69 |
| Price-to-Book | 1.23 |
| Price-to-Sales (TTM) | 425.23 |
| EV/Revenue | 85.18 |
| EV/EBITDA | -0.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $98.05M |
| Float | $95.61M |
| % Insiders | 2.45% |
| % Institutions | 55.20% |
Analyst Ratings
Consensus ($4.36 target)
2
Strong Buy1
Buy7
HoldData last updated: 4/7/2026